YOCHAI BIRNBAUM to Anticoagulants
This is a "connection" page, showing publications YOCHAI BIRNBAUM has written about Anticoagulants.
Connection Strength
1.902
-
Should We Recommend Vitamin K2 Supplement to Prevent Coronary Artery Calcification for Patients Receiving Statins and/or Warfarin? Cardiovasc Drugs Ther. 2025 12; 39(6):1585-1588.
Score: 0.629
-
Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data. J Cardiovasc Pharmacol Ther. 2021 03; 26(2):173-178.
Score: 0.472
-
The CHA2DS2-VASc score: Not as simple as it seems. Int J Cardiol. 2018 04 15; 257:92-96.
Score: 0.396
-
Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians. Expert Rev Cardiovasc Ther. 2024 Sep; 22(9):483-491.
Score: 0.154
-
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
Score: 0.105
-
Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial. Am Heart J. 2006 May; 151(5):976.e1-6.
Score: 0.043
-
Abciximab treatment for obstructive prosthetic aortic and mitral valve thrombosis in the presence of large thrombi, cardiogenic shock, and acute evolving embolic stroke. Echocardiography. 2004 Jan; 21(1):55-9.
Score: 0.037
-
Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials. Eur J Intern Med. 2022 11; 105:38-45.
Score: 0.033
-
The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Cardiovasc Drugs Ther. 2024 06; 38(3):605-619.
Score: 0.033